Clinical Trial Update: Effect of Acetazolamide on Exercise Performance in Patients With Respiratory Disease at Altitude [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating acetazolamide on exercise performance in patients with respiratory disease at altitude (COPD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• ACETAZOLAMIDE (acetazolamide)

Snippet

Sponsor: University of Zurich | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: COMPLETED